机构：[1]Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China[2]Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China[3]Tianjin Institutes of Health Science, Tianjin, China[4]State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin Key Laboratory of Gene Therapy for Blood Diseases, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China[5]West China School of Medicine, Sichuan University, Chengdu, China四川大学华西医院[6]School of Clinical Medicine, Southwest Medical University, Luzhou, China[7]Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, China
Systemic lupus erythematosus (SLE) is an autoimmune inflammatory tissue disease. In view of the explosive growth in research on SLE, bibliometrics was performed to evaluate the 100 top-cited papers in this realm. We performed the search with terms "systemic lupus erythematosus" the Web of Science Core Collection database on May 3, 2023. Relevant literatures were screened. Data were extracted and analyzed by SPSS. The citations of 100 top-cited SLE studies spanned from 472 to 13,557. Most studies (60 out of 100) were conducted in the United States. Total citation times were positively associated with ACY, which was negatively correlated with the length of time since publication. Approximately half of the studies focused on the underlying mechanisms of SLE. New biologic therapies garnered attention and development. Our findings provide valuable insights into the developments in crucial areas of SLE and shed contributions to future studies.
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2024]版：
无
最新[2023]版：
大类|4 区医学
小类|3 区生物工程与应用微生物4 区免疫学
第一作者：
第一作者机构：[1]Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China[2]Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
共同第一作者：
通讯作者：
通讯机构：[2]Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China[7]Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, China
推荐引用方式(GB/T 7714)：
Quan Liuliu,Dai Jiawen,Luo Yuan,et al.The 100 top-cited studies in systemic lupus erythematosus: A bibliometric analysis[J].Human Vaccines & Immunotherapeutics.2024,20(1):2387461.doi:10.1080/21645515.2024.2387461.
APA：
Quan Liuliu,Dai Jiawen,Luo Yuan,Wang Lin,Liu Yue...&You Xin.(2024).The 100 top-cited studies in systemic lupus erythematosus: A bibliometric analysis.Human Vaccines & Immunotherapeutics,20,(1)
MLA：
Quan Liuliu,et al."The 100 top-cited studies in systemic lupus erythematosus: A bibliometric analysis".Human Vaccines & Immunotherapeutics 20..1(2024):2387461
